000			01761 a2200457 4500
005			20250514220138.0
264		0	_c20050728
008			200507s 0 0 eng d
022			_a1535-7163
040			_aNLM _beng _cNLM
100	1		_aKatiyar, Santosh K
245	0	0	_aSilymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. _h[electronic resource]
260			_bMolecular cancer therapeutics _cFeb 2005
300			_a207-16 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAmino Acid Chloromethyl Ketones _xpharmacology
650	0	4	_aAnimals
650	0	4	_aApoptosis
650	0	4	_aApoptotic Protease-Activating Factor 1
650	0	4	_aCaspase 3
650	0	4	_aCaspase Inhibitors
650	0	4	_aCaspases _xmetabolism
650	0	4	_aCell Line
650	0	4	_aCysteine Proteinase Inhibitors _xpharmacology
650	0	4	_aCytochromes c _xmetabolism
650	0	4	_aDown-Regulation
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aKeratinocytes _xdrug effects
650	0	4	_aMice
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPoly(ADP-ribose) Polymerases _xmetabolism
650	0	4	_aProteins _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aSilybin
650	0	4	_aSilymarin _xpharmacology
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
650	0	4	_abcl-2-Associated X Protein
700	1		_aRoy, Anshu M
700	1		_aBaliga, Manjeshwar S
773	0		_tMolecular cancer therapeutics _gvol. 4 _gno. 2 _gp. 207-16
999			_c15389601 _d15389601